Evidence map›Paper›PMID 39271709›Full record

ArticleScientific reports2024

Chronic acetylcholinesterase inhibition reduces the effects of physical training on ventricular contractility and coronary bed reactivity in hypertensive rats.

Karine Pereira Rodrigues, Bruno Augusto Aguilar, Juan Carlos Sánchez-Delgado, Ana Catarine da Veiga, Tallys Eduardo Velasco, Naiara Teixeira Chinellato, Maria Eduarda Dilarri, Hugo Celso Dutra de Souza

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Karine Pereira RodriguesDepartment of Health Science, Ribeirão Preto Medical School of the University of São Paulo, Av. Bandeirantes, 3900-Vila Monte Alegre, Ribeirão Preto, SP, 14049-900, Brazil.
Bruno Augusto AguilarDepartment of Health Science, Ribeirão Preto Medical School of the University of São Paulo, Av. Bandeirantes, 3900-Vila Monte Alegre, Ribeirão Preto, SP, 14049-900, Brazil.
Juan Carlos Sánchez-DelgadoUniversidad Santo Tomás, Bucaramanga, Colombia.
Ana Catarine da VeigaDepartment of Health Science, Ribeirão Preto Medical School of the University of São Paulo, Av. Bandeirantes, 3900-Vila Monte Alegre, Ribeirão Preto, SP, 14049-900, Brazil.
Tallys Eduardo VelascoDepartment of Health Science, Ribeirão Preto Medical School of the University of São Paulo, Av. Bandeirantes, 3900-Vila Monte Alegre, Ribeirão Preto, SP, 14049-900, Brazil.
Naiara Teixeira ChinellatoDepartment of Health Science, Ribeirão Preto Medical School of the University of São Paulo, Av. Bandeirantes, 3900-Vila Monte Alegre, Ribeirão Preto, SP, 14049-900, Brazil.
Maria Eduarda DilarriDepartment of Health Science, Ribeirão Preto Medical School of the University of São Paulo, Av. Bandeirantes, 3900-Vila Monte Alegre, Ribeirão Preto, SP, 14049-900, Brazil.
Hugo Celso Dutra de SouzaDepartment of Health Science, Ribeirão Preto Medical School of the University of São Paulo, Av. Bandeirantes, 3900-Vila Monte Alegre, Ribeirão Preto, SP, 14049-900, Brazil. hugocds@fmrp.usp.br.

Funding

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 001Fundação de Amparo à Pesquisa do Estado de São Paulo 2021/14938-7Fundação de Amparo à Pesquisa do Estado de São Paulo 2022/02553-6Fundação de Amparo à Pesquisa do Estado de São Paulo 2023/13514-4
6 · The paper itself

Abstract

Systemic arterial hypertension is accompanied by autonomic impairments that, if not contained, promotes cardiac functional and morphological damages. Pyridostigmine bromide (PYR) treatment results in positive effects on autonomic control and beneficial cardiac remodeling. These findings were also observed after aerobic physical training (APT). However, little is known about PYR effects on left ventricular contractility, mainly when it is combined with APT. We aimed to investigate the effects of chronic acetylcholinesterase inhibition on cardiac autonomic tone balance, coronary bed reactivity, and left ventricular contractility in spontaneously hypertensive rats (SHR) submitted to APT. Male SHR (18 weeks) were divided into two groups (N = 16): untrained and submitted to APT for 14 weeks (18th to 32nd week). Half of each group was treated with PYR (15 mg/kg/day) for two weeks (31st to 32nd week). The experimental protocol consisted of recording hemodynamic parameters, double autonomic blockade with atropine and propranolol, and assessment of coronary bed reactivity and ventricular contractility in isolated hearts using the Langendorff technique. PYR and APT reduced blood pressure, heart rate, and sympathetic influence on the heart. The Langendorff technique showed that APT increased coronary perfusion pressure and left ventricle contractility in response to coronary flow and β-agonist administration. However, treatment with PYR annulled the effects of APT. In conclusion, although chronic treatment with PYR reduces cardiac sympathetic tonic influence, it does not favor coronary bed reactivity and cardiac contractility gains. PYR treatment in the trained SHR group nullified the coronary vascular reactivity and cardiac contractility gains.

Indexed as

Cholinesterase InhibitorsHypertensionMyocardial ContractionPhysical Conditioning, AnimalPyridostigmine BromideRats, Inbred SHRAcetylcholinesteraseAnimalsBlood PressureCoronary VesselsHeart RateHemodynamicsMaleRatsVentricular Function, LeftAcetylcholinesteraseCholinesterase InhibitorsPyridostigmine BromideAerobic physical trainingAutonomic controlCardiac contractilityContractilityCoronary reactivityHypertensionPyridostigmine bromide

Identifiers

PMID39271709
PMCPMC11399348

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.